GeneCker

GENECKER’S HISTORY

2024

02 Selected as the 10th representative tasks of the Korea Medical Device Development Fund

2023

12 Signing MOU with VIVA INNOVATION for cancer risk testing
11 Joint research on Pancreatic cancer and Bile duct cancer
diagnostic kit (Korea University Hospital)
10 Joint research on Breast cancer diagnostic kit
(Seoul University Hospital,
Catholic University Seoul St. Mary's Hospital)
10 Overseas patent (China) registration (ZL 201980004080.9)
08 Recognition of suitability of manufacturing and quality control
standards for In Vitro diagnostic medical devices (KTL-CABD-18189)
08 Overseas patent (Europe) Registration (365730)
07 Selected for gene editing, control, and restoration base technology
development (R&D) (Ministry of Science and ICT)
04 ISO 9001:2015 certification

04 ISO 13485:2016 certification
03 Overseas patent (USA) Registration (11613776)
02 Genetic Testing Institute Registration (No.414)
02 Signing MOU with Theragen Genome Care
01 Applying PCT (US 18/153, 180)
01 Approval for Class 3 In Vitro diagnostic medical device for export
(External Permission 23-14)

2022

10 Joint research on Pancreatic cancer diagnosis (Asan
Medical Center’s Hepatobiliary and Pancreatic Surgery)
07 Participation in R&D to foster research-oriented hospitals
06 Overseas patent (Japan) Registration (7006873)
04 Series B investment (8 billion)
03 Joint research on Infectious disease diagnostic kit signing MOU with Lab Genomics

2021

12 Approval for the manufacture of In Vitro medical devices
(In Vitro Diagnostic No. 7628)
11 Won the grand prize in the BT category at the 16th Digital Innovation
11 Joint research on Pancreatic cancer, cholangiocarcinoma diagnostic kit (Korea University Hospital)
10 Joint research on Breast cancer diagnostic kit
(Seoul National University Hospital)
10 Commenced joint development of advanced genetic diagnostic kit
(Seoul St.Mary's Hospital Genomic Diagnostic Center)
09 Signing MOU with Korea University for P_HIS business group
(Huniverse Global)
06 Registered as a Support Project for the Startup Leap Package
04 Registered as a Liquid Biopsy Technology Development Project for All-Ministry Medical Devices (1.1 billion)
04 Selected as a scale-up technology commercialization task
03 Completion of GMP manufacturing facilities
02 Registration of 4 types of trademark rights
02 Reaccreditation of the venture company

2020

10 Completed development of new genetic scissors-based micro gene NGS platform
09 Selected as overseas expansion consulting business
(Overseas certification)
07 Passed confirmation of exemption from review by the Korea National Institute for Bioethics Policy, Ministry of Health and Welfare
(Human-derived Materials research)
06 Joint research on Lung Cancer Diagnosis
(Cardiothoracic Surgery, Korea University Anam Hospital)
04 Certification and establishment of a corporate research institute
03 Patent registration (10-2086689)

2019

10 Series a investment (1.5 billion)
10 Series a investment (500 million)
08 Selected as resident company in Biohub Research Experimentsection
(Seoul Metropolitan Government and Ministry of Health and Welfare)
06 Registered as TIPS technology startup team
(Korea Technology and Information Promotion Agency for SMEs)
06 Seed investment (1 million)
06 Seed investment (300 million)
06 TIPS program startup commercialization / Overseas marketing
(Ministry of SMEs and Startups)
02 PCT application
02 Patent application (10-2019-0013912)
02 Venture company certification

2018

09 Startup Success Package Project
(Korea SMEs and Startups Agency)
09 Patent support business
(Korea Health Industry Development Institute)
08 Entering Seoul Bio Hub

2017

11 Incorporation of GeneCker Co., Ltd

Standardization of liquid-biopsy diagnosis
based on ultra-precision CRISPR/Cas9 technology

“Our ultra-precision cancer diagnosis service will provide a new paradigm shift in early
cancer detection with a technology that can selectively analyze a slight amount of cancer
genes in the blood.”

Chief Executive Officer

GENECKER’S VISION

Popularization of cancer diagnosis

Main menu

SITEMAP

COMPANY